Related Experiment Video
Updated: Mar 3, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TXNIP overexpression suppresses proliferation and induces apoptosis in SMMC7221 cells through ROS generation and MAPK
Jian Li1, Zhongyi Yue1, Wancheng Xiong1
1Department of General Surgery, the First Affiliated Hospital, Xinxiang Medical University, Xinxiang, Henan 453100, P.R. China.
Abstract:
Thioredoxin binding protein (thioredoxin-interacting protein, TXNIP), known as vitamin D3 increase protein 1, has been identified as a tumor suppressor in various cancers such as pancreatic, breast, lung and thyroid cancer. However, the role of TXNIP in hepatocellular carcinoma cell proliferation and apoptosis remains unknown. In this study, we first used qRT-PCR, western blotting and immunohistochemistry to compare the expression of TXNIP between hepatocellular carcinoma tissues and tumor-adjacent normal liver tissues. In vitro, we explored the role of TXNIP in hepatocellular carcinoma progression via transfection of the pcDNA-3.1-TXNIP plasmid into SMMC7221 cells. Our results showed that the expression of TXNIP was significantly decreased in hepatocellular carcinoma tissues. Moreover, TXNIP over-expression inhibited hepatocellular carcinoma cell proliferation and induced apoptosis by triggering mitochondrial-mediated ROS generation and activating MAPK pathways. This study provides insight into the molecular mechanisms of TXNIP overexpression in liver cancer cell survival and apoptosis and indicated that TXNIP may be a novel promising agent for liver cancer treatment.
Insights
Thioredoxin binding protein (TXNIP) is decreased in liver cancer. Overexpressing TXNIP inhibits hepatocellular carcinoma cell growth and promotes apoptosis, suggesting its potential as a cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Thioredoxin binding protein (TXNIP) acts as a tumor suppressor in various cancers.
- The role of TXNIP in hepatocellular carcinoma (HCC) progression, proliferation, and apoptosis is not well understood.
Purpose of the Study:
- To investigate the expression levels of TXNIP in HCC tissues.
- To elucidate the functional role of TXNIP in HCC cell proliferation and apoptosis.
Main Methods:
- Quantitative reverse transcription PCR (qRT-PCR) and western blotting were used to assess TXNIP expression.
- Immunohistochemistry was employed to compare TXNIP levels between tumor and adjacent normal tissues.
- In vitro studies involved transfecting SMMC7221 cells with a TXNIP-expressing plasmid.
Main Results:
- TXNIP expression was significantly downregulated in HCC tissues compared to normal liver tissues.
- Overexpression of TXNIP suppressed HCC cell proliferation.
- TXNIP overexpression induced apoptosis through mitochondrial reactive oxygen species (ROS) generation and MAPK pathway activation.
Conclusions:
- TXNIP plays a crucial role in regulating hepatocellular carcinoma cell survival and apoptosis.
- TXNIP functions as a tumor suppressor in HCC by inhibiting proliferation and inducing apoptosis.
- TXNIP represents a potential therapeutic target for liver cancer treatment.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
08:54Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
Published on: March 20, 2016
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades